Prevalence of chronic obstructive lung disease in Korea using data from the fifth Korea national health and nutrition examination survey

Korean Journal of Family Medicine

Volumn 36, Issue 3, 2015, Pages 128-134

  Park, Hwayeon ^a   Jung, Se Young ^a   Lee, Kiheon ^a   Bae, Woo Kyung ^b   Lee, Keehyuck ^a   Han, Jong Soo ^b   Kim, Sarah ^a   Choo, Seryung ^a   Jeong, Jin Mook ^c   Kim, Hyun Ray ^c   Ro, Hyun Jung ^c   Jeong, Hansol ^c  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

Chronic Obstructive Pulmonary Disease; Korea; Prevalence; Pulmonary Function Tests

Indexed keywords

EID: 84930061562     PISSN: 20056443     EISSN: 20926715     Source Type: Journal    
DOI: 10.4082/kjfm.2015.36.3.128     Document Type: Article

References (22)

1. Leidy NK, Haase JE. Functional performance in people with chronic obstructive pulmonary disease: a qualitative analysis. ANS Adv Nurs Sci 1996;18:77-89.
2. Calverley PM, Walker P. Chronic obstructive pulmonary disease. Lancet 2003;362:1053-61.
3. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000;117(2 Suppl):5S9S.
4. World Health Organization. Chronic obstructive pulmonary disease (COPD) fact sheet no. 315 [Internet]. Geneva: World Health Organization; 2013 [cited Nov 17 2014]. Available from: http://www.who.int/mediacentre/factsheets/fs315/en/.
5. Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology 2011;16:659-65.
6. Kim DS, Kim YS, Jung KS, Chang JH, Lim CM, Lee JH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a populationbased spirometry survey. Am J Respir Crit Care Med 2005;172:842-7.
7. Statistics Korea. Korea National Statistical Office [Internet]. Daejeon: Statistics Korea; 2012 [cited Nov 17 2014]. Available from: http://kostat.go.kr/wnsearch/search.jsp.
8. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370:765-73.
9. Sorheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax 2010;65:480-5.
10. Kim YI, Schroeder J, Lynch D, Newell J, Make B, Friedlander A, et al. Gender differences of airway dimensions in anatomically matched sites on CT in smokers. COPD 2011;8:285-92.
11. Rhee HS, Hwang EJ, Hong MH. A comparative study of geriatric disease in rural and urban areas. Korean J Fam Med 1991;12:36-46.
12. Hnizdo E, Sullivan PA, Bang KM, Wagner G. Airflow obstruction attributable to work in industry and occupation among U.S. race/ethnic groups: a study of NHANES III data. Am J Ind Med 2004;46:126-35.
13. Cecere LM, Littman AJ, Slatore CG, Udris EM, Bryson CL, Boyko EJ, et al. Obesity and COPD: associated symptoms, healthrelated quality of life, and medication use. COPD 2011;8:275-84.
14. Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:622-9.
15. Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006;100:115-22.
16. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, TalSinger R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38.
17. Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, et al. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebocontrolled TORCH study. Respir Res 2009;10:59.
18. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009;374:1171-8.
19. Siddique HH, Olson RH, Parenti CM, Rector TS, Caldwell M, Dewan NA, et al. Randomized trial of pragmatic education for lowrisk COPD patients: impact on hospitalizations and emergency department visits. Int J Chron Obstruct Pulmon Dis 2012;7:719-28.
20. Boland MR, Tsiachristas A, Kruis AL, Chavannes NH, Ruttenvan Molken MP. The health economic impact of disease management programs for COPD: a systematic literature review and metaanalysis. BMC Pulm Med 2013;13:40.
21. Jordan TS, Spencer EM, Davies P. Tuberculosis, bronchiectasis and chronic airflow obstruction. Respirology 2010;15:623-8.
22. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009;64:728-35.